MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-14.15%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$512M
AUM Growth
+$512M
(-19%)
Cap. Flow
+$1.59M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$1.59M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 96.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.1B
| $344M | 67.11% | 15,966,038 | – | – |
|
|
2
Esperion Therapeutics
ESPR
$448M
| $103M | 20.13% | 2,629,835 +40,600 | +2% | +$1.59M |
|
3
Alkermes
ALKS
$4.78B
| $42.4M | 8.29% | 1,030,639 | – | – |
|
4
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $10.1M | 1.97% | 400,000 | – | – |
|
5
iShares MSCI India ETF
INDA
$9.17B
| $9.65M | 1.89% | 290,000 | – | – |
|
6
Celldex Therapeutics
CLDX
$1.47B
| $3.18M | 0.62% | 6,312,700 | – | – |
|